Evidence map›Paper›PMID 32231764›Full record

ArticleWorld journal of hepatology2020

Successful liver transplantation for acute sickle cell intrahepatic cholestasis: A case report and review of the literature.

Motasem Alkhayyat, Mohannad Abou Saleh, Mohammad Zmaili, Vedha Sanghi, Tavankit Singh, Carol Rouphael, C Roberto Simons-Linares, Carlos Romero-Marrero, William D Carey, Christina C Lindenmeyer

Open access · diamondAbstract readCase Reports
In one paragraph

Article in World journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Pediatric Acute Liver Failure in Sickle Cell Disease.GE Portuguese journal of gastroenterology · 2022
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Motasem AlkhayyatDepartment of Internal Medicine, Cleveland Clinic, Cleveland, OH 44195, United States.
Mohannad Abou SalehDigestive Disease & Surgery Institute, Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH 44195, United States.
Mohammad ZmailiDepartment of Internal Medicine, Cleveland Clinic, Cleveland, OH 44195, United States.
Vedha SanghiDepartment of Internal Medicine, Cleveland Clinic, Cleveland, OH 44195, United States.
Tavankit SinghDigestive Disease & Surgery Institute, Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH 44195, United States.
Carol RouphaelDigestive Disease & Surgery Institute, Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH 44195, United States.
C Roberto Simons-LinaresDigestive Disease & Surgery Institute, Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH 44195, United States.
Carlos Romero-MarreroDigestive Disease & Surgery Institute, Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH 44195, United States.
William D CareyDigestive Disease & Surgery Institute, Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH 44195, United States.
Christina C LindenmeyerDigestive Disease & Surgery Institute, Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH 44195, United States. lindenc@ccf.org.
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSickle cell hepatopathy (SCH) is an inclusive term referring to any liver dysfunction among patients with sickle cell disease. Acute sickle cell intrahepatic cholestasis is one of the rarest and most fatal presentations of SCH. We present the 23rd reported case of liver transplantation (LT) for SCH; a rare case of acute sickle cell intrahepatic cholestasis managed with LT from a hepatitis C virus (HCV) nucleic acid amplification test positive donor. CASE SUMMARY: A 29-year-old male with a past medical history of sickle cell disease presented with vaso-occlusive pain crisis. On examination, he had jaundice and a soft, non-tender abdomen. Initially he was alert and fully oriented; within 24 h he developed new-onset confusion. Laboratory evaluation was notable for hyperbilirubinemia, leukocytosis, anemia, thrombocytopenia, acute kidney injury and elevated international normalized ratio (INR). Imaging by ultrasound and computed tomography scan suggested a cirrhotic liver morphology with no evidence of biliary ductal dilatation. The patient was diagnosed with acute sickle cell intrahepatic cholestasis after excluding competing etiologies of acute liver injury. He underwent LT from an HCV nucleic acid amplification test positive donor 9 d after initial presentation. The liver explant was notable for widespread sinusoidal dilatation with innumerable clusters of sickled red blood cells and cholestasis. On postoperative day 3, HCV RNA was detectable in the patient's peripheral blood and anti-HCV therapy with glecaprevir/pibrentasvir was initiated on postoperative day 23. He subsequently achieved sustained virologic response after completing 3 mo of therapy and has been followed clinically for 12 mo post-transplant.

conclusionThis case highlights the utility of LT as a viable treatment option for acute sickle cell intrahepatic cholestasis.

Indexed as

Acute intrahepatic cholestasisCase reportHepatitis C virusLiver transplantPost-operative surveillanceSickle cell hepatopathy

Identifiers

PMID32231764
PMCPMC7097501
OpenAlexW3013717782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.